Skip to main content
. 2022 May 18;11:e73656. doi: 10.7554/eLife.73656

Table 2. Crosses to obtain embryos used in each experiment.

Cross Figure
His2Av::RFP; nos-MCP::GFP x ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Falo-Sanjuan et al., 2019 (Figure 1, Figure 1—figure supplement 1)
His2Av::RFP; nos-MCP::GFP x ♂ m5/m8-peve-MS2-lacZ-SV40[attP2,III] Falo-Sanjuan et al., 2019 Figure 1—figure supplement 1
His2Av::RFP; nos-MCP::GFP x ♂ sim-peve-MS2-lacZ-SV40[attP40,II] Falo-Sanjuan et al., 2019 Figure 1—figure supplement 1
His2Av::RFP; nos-MCP::GFP x ♂ m5/m8-pm7-MS2-lacZ-SV40[attP40,II] Falo-Sanjuan et al., 2019 Figure 1—figure supplement 1
His2Av::RFP; nos-MCP::GFP x ♂ m5/m8-psimE-MS2-lacZ-SV40[attP40,II] Falo-Sanjuan et al., 2019 Figure 1—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-w RNAim5/m8-peve-MS2-lacZ-SV40[attP40,II] Figures 2; 5; 6, Figure 2—figure supplements 1; 2; 4, Figure 3—figure supplement 1, Figure 5—figure supplement 2, Figure 6—figure supplement 3
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-α-Cat RNAim5/m8-peve-MS2-lacZ-SV40[attP40,II] Figures 2; 6, Figure 2—figure supplements 1; 2
His2Av::RFP, nos-MCP::GFP (III) x ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 2, Figure 2—figure supplements 1; 2, Figure 6—figure supplement 3
fog[S4] / FM6;; His2Av::RFP, nos-MCP::GFP x ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 2, Figure 2—figure supplements 1; 2, Figure 6—figure supplement 3
αTub-Gal4::VP16 / UASpcta RNAi; His2Av::RFP, nos-MCP::GFP / + ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 2, (Figure 2—figure supplements 1; 2) , Figure 6—figure supplement 3
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-RhoGEF2 RNAim5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 2, (Figure 2—figure supplements 1; 2) , Figure 6—figure supplement 3
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-w RNAim5/m8-peve-MS2-lacZ-SV40[attP2,III] Falo-Sanjuan and Bray, 2021 Figure 2—figure supplement 3
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-α-Cat RNAim5/m8-peve-MS2-lacZ-SV40[attP2,III] Falo-Sanjuan and Bray, 2021 Figure 2—figure supplement 3
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-w RNAisim-peve-MS2-lacZ-SV40[attP40,II] Figure 2—figure supplement 3
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-α-Cat RNAisim-peve-MS2-lacZ-SV40[attP40,II] Figure 2—figure supplement 3
αTub-Gal4::VP16 / UASpzld RNAi; His2Av::RFP, nos-MCP::GFP / + ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 2—figure supplement 4
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-grh RNAim5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 2—figure supplement 4
♀ x ♂ αTub-Gal4::VP16 / +; zld::GFP / UASp-w RNAi Figure 2—figure supplement 4
♀ x ♂ αTub-Gal4::VP16 / UASpzld RNAi; zld::GFP / + Figure 2—figure supplement 4
His2Av::RFP, nos-MCP::GFP (III) x ♂ vndEEE-peve-MS2-lacZ-SV40[attP40,II] Figure 3, Figure 3—figure supplement 1
αTub-Gal4::VP16 /+; His2Av::RFP, nos-MCP::GFP / UASp-w RNAivndEEE-peve-MS2-lacZ-SV40[attP40,II] Figure 3, Figure 3—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-α-Cat RNAivndEEE-peve-MS2-lacZ-SV40[attP40,II] Figure 3, Figure 3—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-Notch RNAi ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 3—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-Notch RNAivndEEE-peve-MS2-lacZ-SV40[attP40,II] Figure 3, Figure 3—figure supplement 1
fog[S4] / FM6 ;; His2Av::RFP, nos-MCP::GFP x ♂ vndEEE-peve-MS2-lacZ-SV40[attP40,II] Figure 3, Figure 3—figure supplement 1
ovo-FLP / +; eve2-FRT-STOP-FRT-NICD / +; His2Av::RFP, nos-MCP::GFP / + ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 4, Figure 4—figure supplement 1
ovo-FLP / fog[S4]; eve2-FRT-STOP-FRT-NICD / +; His2Av::RFP, nos-MCP::GFP / + ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 4, Figure 4—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-w RNAiβTub85D-FLP; m5/m8-peve-MS2-lacZ-SV40, eve2-FRT-STOP-FRT-NICD / + Figure 4, Figure 4—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-Notch RNAiβTub85D-FLP; m5/m8-peve-MS2-lacZ-SV40, eve2-FRT-STOP-FRT-NICD / + Figure 4, Figure 4—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-α-Cat RNAiβTub85D-FLP; m5/m8-peve-MS2-lacZ-SV40, eve2-FRT-STOP-FRT-NICD / + Figure 4, Figure 4—figure supplement 1
αTub-Gal4::VP16 / +; His2Av::RFP, nos-MCP::GFP / UASp-klar RNAim5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 5
♀ x ♂ αTub-Gal4::VP16 / +; UASp-w RNAi / + (for qPCR) Figure 5—figure supplement 2
♀ x ♂ αTub-Gal4::VP16 / UASpkoi RNAi; +/+ (for qPCR) Figure 5—figure supplement 2
♀ x ♂ αTub-Gal4::VP16 / +; UASp-klar RNAi / + (for qPCR) Figure 5—figure supplement 2
Gap43::mCherry; nos-MCP::GFP x ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Falo-Sanjuan and Bray, 2021 Figure 5—figure supplement 1
♀ x ♂ His2Av::iRFP, nos-MCP::mCherry / CyO; nos-MCP::mCherry, vasa-eGFP Figure 6—figure supplement 1
♀ x ♂ ubi-nls::GFP, FRT80E Figure 6—figure supplement 1
♀ x ♂ nos-nls::PCP::GFP Figure 6—figure supplement 1
♀ x ♂ His2Av::RFP / + (dextran injected) Figure 6—figure supplement 1
♀ x ♂ med4-GFP Figure 6—figure supplement 1
♀ x ♂ med30-GFP Figure 6—figure supplement 1
♀ x ♂ skd-venus Figure 6—figure supplement 1
His2Av::iRFP, nos-MCP::mCherry / CyO; nos-MCP::mCherry, Su(H)::GFPm5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 6—figure supplement 1
♀ x ♂ H::GFP; His2Av::RFP Figure 6—figure supplement 1
♀ x ♂ nej-venus Figure 6—figure supplement 1
Vasa-mCherry (III) x ♂ Twi-JB10/CyO Figure 6
Nup107::RFP, nos-MCP::GFP x ♂ m5/m8-peve-MS2-lacZ-SV40[attP40,II] Figure 6, Figure 6—figure supplement 2